Publication | Open Access

Anti-inflammatory activities of Levilactobacillus brevis KU15147 in RAW 264.7 cells stimulated with lipopolysaccharide on attenuating NF-κB, AP-1, and MAPK signaling pathways

InflammationAnti-inflammatoryMedicineImmune RegulationImmunologyChronic InflammationRaw 264.7Immune SystemHumoral ImmunityImmune FunctionInnate ImmunityDisease BiologyAnti-inflammatory ActivitiesMetabolic SignalingMapk Signaling PathwaysCell BiologyCell Signaling